393 related articles for article (PubMed ID: 8586691)
41. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
Thornton C; Johnson G; Agrawal S
J Vis Exp; 2012 Mar; (61):. PubMed ID: 22473419
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
43. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
[TBL] [Abstract][Full Text] [Related]
44. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
[TBL] [Abstract][Full Text] [Related]
45. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies.
Luong ML; Filion C; Labbé AC; Roy J; Pépin J; Cadrin-Tourigny J; Carignan S; Sheppard DC; Laverdière M
Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585
[TBL] [Abstract][Full Text] [Related]
46. Invasive pulmonary aspergillosis diagnosed early by polymerase chain reaction assay.
Kawamura S; Maesaki S; Omagari K; Hashiguchi K; Tomono K; Tashiro T; Kohno S
Intern Med; 1999 Sep; 38(9):744-6. PubMed ID: 10480308
[TBL] [Abstract][Full Text] [Related]
47. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
48. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
Serin I; Dogu MH
Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
[TBL] [Abstract][Full Text] [Related]
49. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome.
Salonen J; Lehtonen OP; Teräsjärvi MR; Nikoskelainen J
Scand J Infect Dis; 2000; 32(5):485-90. PubMed ID: 11055651
[TBL] [Abstract][Full Text] [Related]
50. Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis.
Rantakokko-Jalava K; Laaksonen S; Issakainen J; Vauras J; Nikoskelainen J; Viljanen MK; Salonen J
J Clin Microbiol; 2003 Sep; 41(9):4304-11. PubMed ID: 12958261
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
[TBL] [Abstract][Full Text] [Related]
53. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
[TBL] [Abstract][Full Text] [Related]
54. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
[TBL] [Abstract][Full Text] [Related]
55. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis.
Kami M; Fukui T; Ogawa S; Kazuyama Y; Machida U; Tanaka Y; Kanda Y; Kashima T; Yamazaki Y; Hamaki T; Mori S; Akiyama H; Mutou Y; Sakamaki H; Osumi K; Kimura S; Hirai H
Clin Infect Dis; 2001 Nov; 33(9):1504-12. PubMed ID: 11588697
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the new AspID polymerase chain reaction assay for detection of Aspergillus species: A pilot study.
Prattes J; Hoenigl M; Zinke SE; Heldt S; Eigl S; Johnson GL; Bustin S; Stelzl E; Kessler HH
Mycoses; 2018 Jun; 61(6):355-359. PubMed ID: 29460450
[TBL] [Abstract][Full Text] [Related]
57. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
58. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.
Kono Y; Tsushima K; Yamaguchi K; Kurita N; Soeda S; Fujiwara A; Sugiyama S; Togashi Y; Kasagi S; To M; To Y; Setoguchi Y
Respir Med; 2013 Jul; 107(7):1094-100. PubMed ID: 23632100
[TBL] [Abstract][Full Text] [Related]
59. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
60. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
